BG105066A - A mutant human hepatitis b viral strain and uses thereof - Google Patents

A mutant human hepatitis b viral strain and uses thereof

Info

Publication number
BG105066A
BG105066A BG105066A BG10506600A BG105066A BG 105066 A BG105066 A BG 105066A BG 105066 A BG105066 A BG 105066A BG 10506600 A BG10506600 A BG 10506600A BG 105066 A BG105066 A BG 105066A
Authority
BG
Bulgaria
Prior art keywords
nucleic acid
hepatitis
virus
isolated nucleic
provides
Prior art date
Application number
BG105066A
Other languages
Bulgarian (bg)
English (en)
Inventor
Chong OON
Gek LIM
Yi Zhao
Wei Chen
Original Assignee
Government Of The Republic Of Singapore
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Government Of The Republic Of Singapore filed Critical Government Of The Republic Of Singapore
Publication of BG105066A publication Critical patent/BG105066A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
BG105066A 1998-06-19 2000-12-18 A mutant human hepatitis b viral strain and uses thereof BG105066A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/SG1998/000046 WO1999066048A1 (en) 1998-06-19 1998-06-19 A mutant human hepatitis b viral strain and uses thereof

Publications (1)

Publication Number Publication Date
BG105066A true BG105066A (en) 2001-09-28

Family

ID=20429862

Family Applications (1)

Application Number Title Priority Date Filing Date
BG105066A BG105066A (en) 1998-06-19 2000-12-18 A mutant human hepatitis b viral strain and uses thereof

Country Status (22)

Country Link
US (1) US6558675B1 (uk)
EP (1) EP1098981A1 (uk)
JP (1) JP2002518014A (uk)
KR (1) KR100498118B1 (uk)
CN (1) CN1322251A (uk)
AR (1) AR020093A1 (uk)
AU (1) AU756866B2 (uk)
BG (1) BG105066A (uk)
BR (1) BR9815913A (uk)
CA (1) CA2330935C (uk)
HU (1) HUP0103409A3 (uk)
IL (1) IL140364A0 (uk)
IS (1) IS5778A (uk)
MX (1) MXPA00012720A (uk)
MY (1) MY118955A (uk)
NO (1) NO20006456L (uk)
NZ (1) NZ508890A (uk)
PL (1) PL192129B1 (uk)
TR (1) TR200003777T2 (uk)
UA (1) UA73476C2 (uk)
WO (1) WO1999066048A1 (uk)
YU (1) YU80600A (uk)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200643171A (en) 2005-06-07 2006-12-16 Temasek Life Sciences Lab Ltd Porcine circovirus type 2 vaccines
BR112022005687A2 (pt) 2019-09-30 2022-06-21 Gilead Sciences Inc Vacinas contra o hbv e métodos para tratar o hbv
CN113201051B (zh) * 2021-04-27 2022-08-02 复旦大学 一种乙肝病毒表面蛋白突变体及其在抗乙肝病毒中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9401987D0 (en) * 1994-02-02 1994-03-30 Imperial College Modified nucleic acid
US5980901A (en) * 1996-09-18 1999-11-09 The Board Of Regents Of The University Of Texas System Viral defective interfering particles and uses thereof

Also Published As

Publication number Publication date
MY118955A (en) 2005-02-28
TR200003777T2 (tr) 2001-06-21
CN1322251A (zh) 2001-11-14
BR9815913A (pt) 2001-12-26
NZ508890A (en) 2004-04-30
WO1999066048A1 (en) 1999-12-23
KR100498118B1 (ko) 2005-07-01
AU756866B2 (en) 2003-01-23
IS5778A (is) 2000-12-19
JP2002518014A (ja) 2002-06-25
PL345573A1 (en) 2001-12-17
HUP0103409A2 (hu) 2001-12-28
IL140364A0 (en) 2002-02-10
US6558675B1 (en) 2003-05-06
AR020093A1 (es) 2002-04-10
NO20006456L (no) 2001-02-16
NO20006456D0 (no) 2000-12-18
HUP0103409A3 (en) 2003-10-28
UA73476C2 (en) 2005-08-15
EP1098981A1 (en) 2001-05-16
CA2330935C (en) 2005-05-10
KR20010106129A (ko) 2001-11-29
CA2330935A1 (en) 1999-12-23
MXPA00012720A (es) 2002-05-08
YU80600A (sh) 2005-06-10
PL192129B1 (pl) 2006-09-29
AU7795198A (en) 2000-01-05

Similar Documents

Publication Publication Date Title
Rottier et al. Predicted membrane topology of the coronavirus protein E1
NZ336929A (en) Purified receptor that binds TRAIL and antibodies thereof
KR960704038A (ko) 세포 표면 수용체 Hek와 결합하는 사이토킨(Cytokines That Bind the Cell Surface Receptor Hek)
EP1018557A3 (en) Infectious cDNA clone of north american porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
JP2003516731A5 (uk)
CA2209360A1 (en) Recombinant monoclonal anti-idiotype antibody 3h1 sequences relating to human carcinoembryonic antigen
NZ502391A (en) Mammalian cytokine: interleukin-B30 and related reagents
WO1995001442A3 (en) Nucleotide and amino acid sequences of the envelope 1 gene of 51 hepatitis c virus isolates and the use of reagents derived therefrom as diagnostic reagents and vaccines
JP2009529868A5 (uk)
CA2272845A1 (en) Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes
CA2179909A1 (en) Ligand that binds fas antigen
BG105065A (en) A vaccine-induced hepatitis b viral strain and uses thereof
CA2188279A1 (en) Interleukin-15 receptors
AU3406595A (en) Nucleotide and amino acid sequences of the envelope 1 and core genes of hepatitis c virus
CA2135278A1 (en) Peptide for stimulation of cytotoxic t lymphocytes specific for hepatitis c virus
Baron et al. Antibodies against a synthetic peptide of the poliovirus replicase protein: reaction with native, virus-encoded proteins and inhibition of virus-specific polymerase activities in vitro
BG105066A (en) A mutant human hepatitis b viral strain and uses thereof
AU5776799A (en) Modified hcv peptide vaccines
WO2003097814A3 (en) Scytovirins and related conjugates, fusion proteins, nucleic acids, vectors, host cells, compositions, antibodies and methods of using scytovirins
CA2241786A1 (en) Novel amp activated protein kinase
CA2374513A1 (en) Il-1 eta dna and polypeptides
TH46562A3 (th) สายพันธุ์ไวรัสมิวแทนท์ฃเฮพาไททิส บี ของคนและการใช้งานของมัน
WO2004056316A3 (en) Vaccines against hiv-1 tat protein to generate neutralizing antibodies
CA2326699A1 (en) Gene 62 of oka vaccine virus and method for identifying virus strain for live attenuated vaccine virus using the gene 62
EP0949333A4 (en) MUTANT ANTIGENS OF MEASURE VIRUS AND GENES ENCODING THEM